DGX
Quest Diagnostics·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 2
Bearish signal 1
High Cash/net Profit Ratio
Revenue Beats Expectation
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About DGX
Quest Diagnostics Incorporated
The nation's leading provider of diagnostic information services
Healthcare Providers and Services
--
12/17/1996
New York Stock Exchange
45,000
12-31
Common stock
500 Plaza Drive
, Secaucus
, NJ 07094
--
Quest Diagnostics Incorporated was founded in Delaware in 1990. The company is the world's leading provider of diagnostic information services. Companies play a crucial role in the healthcare ecosystem, empowering people to take action to improve their health. From the world's largest database of clinical laboratory results, its diagnostic insights reveal new ways to identify and treat diseases, motivate healthy behaviors and improve medical management. In the right people and in the right context, its diagnostic insights can inspire life-changing actions.
Earnings Call
Company Financials
EPS
DGX has released its 2025 Q3 earnings. EPS was reported at 2.6, versus the expected 2.5, beating expectations. The chart below visualizes how DGX has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
DGX has released its 2025 Q3 earnings report, with revenue of 2.82B, reflecting a YoY change of 13.18%, and net profit of 259.00M, showing a YoY change of 9.28%. The Sankey diagram below clearly presents DGX's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available

